Mortality among Patients with COVID-19 and Different Interstitial Lung Disease Subtypes: A Multicenter Cohort Study
Open Access
- 1 August 2022
- journal article
- letter
- Published by Oxford University Press (OUP) in Annals of the American Thoracic Society
- Vol. 19 (8) , 1435-1437
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Increased Odds of Death for Patients with Interstitial Lung Disease and COVID-19: A Case–Control StudyAmerican Journal of Respiratory and Critical Care Medicine, 2020
- Intellectual and developmental disability and COVID-19 case-fatality trends: TriNetX analysisDisability and Health Journal, 2020
- Clinical characteristics of COVID‐19 in patients with preexisting ILD: A retrospective study in a single center in Wuhan, ChinaJournal of Medical Virology, 2020
- Coronaviruses and SARS-CoV-2: A Brief OverviewAnesthesia & Analgesia, 2020
- WHO Declares COVID-19 a Pandemic2020
- Autoantibodies against the Immunoglobulin-Binding Region of Ro52 Link its Autoantigenicity with Pathogen NeutralizationScientific Reports, 2018
- Diffuse Cystic Lung Disease as the Presenting Manifestation of Sjögren SyndromeAnnals of the American Thoracic Society, 2016
- Role of the lipoxygenase pathway in RSV-induced alternatively activated macrophages leading to resolution of lung pathologyMucosal Immunology, 2013
- Significance of connective tissue diseases features in pulmonary fibrosisEuropean Respiratory Review, 2013
- Fibrosing Alveolitis Associated with Systemic Sclerosis Has a Better Prognosis Than Lone Cryptogenic Fibrosing AlveolitisAmerican Journal of Respiratory and Critical Care Medicine, 1994